
Why Is Philippe Laffont Buying TSM?
With a personal net worth of approximately $6.5 billion and…
Trailing 12 Months | Fiscal Quarters | |||||
---|---|---|---|---|---|---|
Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
Income Statement | ||||||
Revenue | $1.4B | $1.7B | $2.5B | $456.7M | $692.4M | |
Gross Profit | $187.2M | $189.2M | $258M | $58.8M | $79M | |
Operating Income | -$120M | -$138M | -$120.9M | -$29.8M | -$19.5M | |
EBITDA | -$105.5M | -$116.7M | -$94.6M | -$24.1M | -$11.8M | |
Diluted EPS | -$0.78 | -$0.85 | -$0.77 | -$0.19 | -$0.14 |
Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
---|---|---|---|---|---|---|
Balance Sheet | ||||||
Current Assets | -- | $577.4M | $692.2M | $667M | $573.6M | |
Total Assets | -- | $656.9M | $777.5M | $770.8M | $692.3M | |
Current Liabilities | -- | $175.1M | $340.3M | $410.3M | $358.1M | |
Total Liabilities | -- | $331.9M | $505.4M | $581.2M | $576.7M | |
Total Equity | -- | $325.1M | $272.1M | $189.6M | $115.6M | |
Total Debt | -- | $149M | $160.7M | $161.6M | $212M |
Trailing 12 Months | Fiscal Quarters | |||||
---|---|---|---|---|---|---|
Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
Cash Flow Statement | ||||||
Cash Flow Operations | $73.7M | -$21M | -$144M | $6M | $26.2M | |
Cash From Investing | -$23.1M | -$154.4M | $44.1M | -$9.6M | -$24.6M | |
Cash From Financing | $17.1M | -$467K | $49.2M | -- | -- | |
Free Cash Flow | $53.4M | -$52.8M | -$186.7M | -$3.6M | $16.9M |
Alignment Healthcare Inc is a next-generation, consumer-centric platform that is revolutionizing the healthcare experience for seniors through Medicare Advantage plans. These plans are marketed and sold direct-to-consumer, allowing seniors to select the manner in which customers receive healthcare coverage and services on an annual basis. The company combines a technology platform and clinical model for more effective health outcomes.
In the current month, ALHC has received 8 Buy ratings 3 Hold ratings, and 0 Sell ratings. The ALHC average analyst price target in the past 3 months is $14.00.
According to analysts, the consensus estimate is that Alignment Healthcare share price will rise to $14.00 per share over the next 12 months.
Analysts are divided on their view about Alignment Healthcare share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Alignment Healthcare is a Sell and believe this share price will drop from its current level to $8.00.
The price target for Alignment Healthcare over the next 1-year time period is forecast to be $14.00 according to 11 Wall Street analysts, 8 of them rate the stock a Buy, 0 rate the stock a Sell, and 3 analysts rate the stock a Hold.
According to Wall Street analysts, the consensus rating for Alignment Healthcare is a Buy. 8 of 11 analysts rate the stock a Buy at this time.
You can purchase shares of Alignment Healthcare via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Alignment Healthcare shares.
Alignment Healthcare was last trading at $13.42 per share. This represents the most recent stock quote for Alignment Healthcare. Yesterday, Alignment Healthcare closed at $13.18 per share.
In order to purchase Alignment Healthcare stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Signup to receive the latest stock alerts
With a personal net worth of approximately $6.5 billion and…
The degree to which the healthcare paradigm has changed is…
While the world focuses on AI, the leaders over at…
Market Cap: $3.7T
P/E Ratio: 40x
Market Cap: $3.3T
P/E Ratio: 113x
Market Cap: $3T
P/E Ratio: 35x
Globant SA [GLOB] is up 2.83% over the past day.
Hims & Hers Health [HIMS] is down 19.28% over the past day.
Vicor [VICR] is down 5.16% over the past day.